The Cigna Group's long-time CEO David M. Cordani will retire effective July 1 and be replaced by current president and chief ...
Bernstein upgraded both Cigna Group and CVS Health Corp to Outperform in separate notes on Thursday, arguing that sweeping pharmacy benefit manager (PBM) reforms have removed a major overhang for the ...
Cigna names company veteran Brian Evanko as CEO to succeed David Cordani, who has been in charge for 27 years.
Cigna delivered another quarter of strong revenue and EPS beats, yet remains deeply discounted versus sector peers. Read why CI stock is a Buy.
Scoop: Cigna has acquired CarepathRx, a large pharmacy backed by private equity that dispenses prescription drugs to nearly ...
Cigna's Evernorth has acquired CarepathRx just two years after making a significant investment in the company, a spokesperson confirmed to Fierce Healthcare. | Cigna's Evernorth has acquired ...
Cordani will leave the CEO chair on July 1 and step into the role of executive chair of the company's board of directors.
Bloomfield-based health insurer The Cigna Group said Tuesday that President and Chief Operating Officer Brian Evanko will succeed David M. Cordani as chief executive officer, effective July 1, 2026.
The retirement of David Cordani as CEO of The Cigna Group will be the fourth departure of a long-time health insurance ...
Cigna Group’s longtime leader, David Cordani, is retiring as chief executive of the health insurer later this year and handing the reins to Brian Evanko.
The Cigna Group (NYSE:CI) is one of the Best Value Stocks to Buy for the Long Term. On March 3, The Cigna Group (NYSE:CI) ...
Analysts said Evanko had been seen as a natural successor to Cordani, who will become the executive chair of the board.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results